Domestic Violence Enhanced Home Visitation Program (DOVE)
NCT ID: NCT00465556
Last Updated: 2015-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
239 participants
INTERVENTIONAL
2006-02-28
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the study is to test the effect of home visits on reducing domestic violence and improving the lives of pregnant women and their children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Intimate Partner Violence Screening-Intervention
NCT00257296
Telephone Intervention to Increase Safety in Abused Women
NCT00457522
Safety and Effectiveness of Computer Screening for Intimate Partner Violence
NCT00166062
Enhanced Nurse Home Visitation to Prevent Intimate Partner Violence
NCT01811719
The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women
NCT03259646
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Dove Intervention
Public Health Nurse Home Visit
The perinatal public health nurse home visit intervention also includes a trifold brochure, printed on 8X10 inch paper, with 6 panels, that can be read with the woman in an interactive manner so that the woman is encouraged to describe her experiences and choose her options as they proceed. Participants will receive three prenatal and three postpartum sessions. The first prenatal sessions will be given during the first (enrollment), second, and third trimesters, with at least three weeks between sessions. Women entering the study after the first trimester will receive the initial session at enrollment, with two subsequent sessions spread out over the remainder of the scheduled prenatal home visitation program sessions.
2
Intimate Partner Violence (IPV) Protocol
Intimate Partner Violence (IPV) Protocol
The current protocol in use by the participating health departments when a women screens positive for intimate partner violence (IPV), current or history within the last year.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Public Health Nurse Home Visit
The perinatal public health nurse home visit intervention also includes a trifold brochure, printed on 8X10 inch paper, with 6 panels, that can be read with the woman in an interactive manner so that the woman is encouraged to describe her experiences and choose her options as they proceed. Participants will receive three prenatal and three postpartum sessions. The first prenatal sessions will be given during the first (enrollment), second, and third trimesters, with at least three weeks between sessions. Women entering the study after the first trimester will receive the initial session at enrollment, with two subsequent sessions spread out over the remainder of the scheduled prenatal home visitation program sessions.
Intimate Partner Violence (IPV) Protocol
The current protocol in use by the participating health departments when a women screens positive for intimate partner violence (IPV), current or history within the last year.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Nursing Research (NINR)
NIH
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Phyllis Sharps
Professor, Associate Dean
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phyllis Sharps, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baltimore City Health Department
Baltimore, Maryland, United States
Missouri Department of Health and Senior Services; Missouri Community Based Home Visiting Program and Lutheran and Family Children's Services in Columbia and Springfield
Columbia, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kalra N, Hooker L, Reisenhofer S, Di Tanna GL, Garcia-Moreno C. Training healthcare providers to respond to intimate partner violence against women. Cochrane Database Syst Rev. 2021 May 31;5(5):CD012423. doi: 10.1002/14651858.CD012423.pub2.
Sharps PW, Bullock LF, Campbell JC, Alhusen JL, Ghazarian SR, Bhandari SS, Schminkey DL. Domestic Violence Enhanced Perinatal Home Visits: The DOVE Randomized Clinical Trial. J Womens Health (Larchmt). 2016 Nov;25(11):1129-1138. doi: 10.1089/jwh.2015.5547. Epub 2016 May 20.
Sharps P, Alhusen JL, Bullock L, Bhandari S, Ghazarian S, Udo IE, Campbell J. Engaging and retaining abused women in perinatal home visitation programs. Pediatrics. 2013 Nov;132 Suppl 2(Suppl 2):S134-9. doi: 10.1542/peds.2013-1021L.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NR009093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.